The role of surgery and treatment trends in uterine sarcoma

European Journal of Surgical Oncology

Volumn 31, Issue 4, 2005, Pages 434-442

  Benoit, Laurent ^a,c   Arnould, L ^b   Cheynel, N ^a   Goui, S ^b   Collin, F ^b   Fraisse, J ^b   Cuisenier, J ^b  

^a HÔPITAL DU BOCAGE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c NONE   (France)

Author keywords

Metastases; Pelvic recurrences; Surgery; Uterine sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; VINCRISTINE;

ABDOMINAL PAIN; ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM SARCOMA; FEMALE; GENITAL BLEEDING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; METASTASIS; MIXED MULLERIAN TUMOR; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROBABILITY; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; SARCOMA; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 17144413782     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.01.010     Document Type: Article

References (31)

1. F.A. Tavassoli P. Devilee World Health Organization Classification of Tumours editors. In: Pathology and genetics of tumours of the breast and female genital organs 2003 IARC Press Lyon
2. E. Moskovic E. Macsweeney M. Law A. Price Survival patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients Br J Radiol 66 1993 1009-15
3. L. Chauveinc E. Deniaud C. Plancher X. Sastre F. Amsani A. de la Roch et al. Uterine sarcomas: The Curie institute experience. Prognosis factors and adjuvant treatments Gynecol Oncol 72 1999 232-7
4. A. Gadducci E. Sartori F. Landoni P. Zola T. Maggino S. Cosio et al. The prognostic relevance of histological type in uterine sarcoma. Cooperation task force (CTF) multivariate analysis of 249 cases Eur J Gynaecol Oncol 23 2002 295-9
5. B. Jereczek J. Jassem A. Kobierska Sarcoma of the uterus. A clinical study of 42 patients Arch Gynecol Obstet 258 1996 171-80
6. T.H. Knocke H. Kucera D. Dorfler B. Pokrajac R. Potter Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri Cancer 83 1998 1972-9
7. L. Livi E. Andreopoulou N. Shah F. Paiar P. Blake I. Judson et al. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998 Clin Oncol 16 2004 261-8
8. K.S. Olah J.A. Dunn H. Gee Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known pronostic factors: The result of a retrospective study of 423 cases of uterine sarcoma Br J Obstet Gynaecol 99 1992 590-4
9. G.A. Omura J.A. Blessing F. Major S. Lifshitz C.E. Ehrlich C. Mangan et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study J Clin Oncol. 3 1985 1240-5
10. F.J. Major J.A. Blessing S.G. Silverberg C.P. Morrow W.T. Creasman J.L. Currei et al. Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 1993 1702-9
11. S.S. Chen Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus Gynecol Oncol 32 1989 215-7
12. T.V. Dinh R.E. Slavin B.S. Bhagavan E.V. Hannigan E.M. Tiamson R.B. Yandell Mixed Mullerian tumours of the uterus: A clinicopathologic study Obstet Gynecol 74 1989 388-92
13. S.D. Tinkler V.J. Cowie Uterine sarcoma: A review of the Edinburgh experience from 1974 to 1992 Br J Radiol 66 1993 998-1001
14. W.A. Peters W.P. Fleming G.W. Morley Prognostic features of sarcomas and mixed tumors of the endometrium Obstet Gynecol 63 1984 550-6
15. E.S. Podczaski C.A. Woomert C.W. Stevens A. Manetta J.E. Larson R.J. Zaino et al. Management of malignant, mixed mesodermal tumors of the uterus Gynecol Oncol 32 1989 240-4
16. G. Wain N. Hacker Clinical features and treatment of genital sarcomas In: E. Burghardt M. Webb J. Monaghan G. Kinderman editors. Surgical gynecologic oncology 1993 geog Thieme Verlag Editor New York
17. A. Gadducci E. Sartori F. Landoni P. Zola T. Maggino A. Urgesi Endometrial stroma sarcoma: Analysis of treatment failures and survival Gynecol Oncol 63 1996 247-53
18. P. Morice A. Rodrigues P. Pautier A. Rey S. Camatte D. Atallah et al. Chirurgie des sarcomes utérins: Revue de la littérature et recommandations sur la prise en charge chirurgicale Gynécol obstét fert 31 2003 147-50
19. B.A. Goff L.W. Rice D. Fleischacker H.G. Muntz S.S. Falkenberry N. Nikrui Uterine leiomyosarcoma and endometrial stroma sarcoma: Lymph node metastases and site of recurrence Gynecol Oncol 50 1993 105-9
20. P.J. Disaia C.B. Morrow R. Boronow W. Creasman L. Mittelstaedt Endometrial sarcomas; lymphatic spread pattern Am J Obstet Gynecol 130 1978 104-5
21. W.J. Sanos J.T. Wharton L. Gomez G.H. Fletcher M.J. Oswald Malignant mixed Mullerian tumors of the uterus Cancer 53 1984 311
22. C. Levenback S.C. Rubin P.M. McCormack W.J. Hoskins E.N. Atkinson J.L. Lewis Resection of pulmonary metastases from uterine sarcomas Gynecol Oncol 45 1992 202-5
23. T. Anderson J. Mc Mahon C. Nwogu M. Pombo J. Urschel D. Driscoll et al. Pulmonary resection in metastatic uterine and cervical malignancies Gyneol Oncol 83 2001 472-6
24. M. Leitao M. Brennan M. Hensley Y. Sonoda A. Hummer D. Bhaskaran et al. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma Gynecol Oncol; 87 2002 287-92
25. H. Lang K.T. Nussbaum P. Kaudel N. Fruhauf P. Flemming R. Raad Hepatic metastases from leiomyosarcoma; a single-center experience with 34 liver resections during 15-year period Ann Surg 231 2000 500-5
26. Reed NS, Mangioni C, Malmstrom H, Scafore A, Poveda A, Tateo S, et al. First results of a randomised trial comparing radiotherapy versus observation post operatively in patients with uterine sarcomas. An EORTC-GSG study. Int J Gynecol Cancer 2003;13(Suppl 1):1-122.
27. G. Tore E. Toppuz N. Bilce I. Aslay M. Dincer A. Elgin The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients Eur J Gynaecol Oncol 11 1990 307-12
28. R.R. Nordal S.O. Thoresen Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality Eur J Cancer 33 1997 907-11
29. G. Sutton J.A. Blessing J.H. Malfetano Isofosfamide and doxorubicin in the treatment of advanced leiomyosarcoma of the uterus: A Gynecologic Oncologic Group study Gynecol Oncol 62 1996 226-9
30. J.H. Edmonson J.A. Blessing J.A. Cosin D.S. Miller D.E. Cohn Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: A Gynecologic Oncolgy Group study Gynecol Oncol 85 2002 507-10
31. G. Sutton J.A. Blessing H. Ball Phase II trial of paclitaxel in leiomyosarcoma of the uterus: A gynecologic oncology group study Gynecol Oncol. 74 3 1999 346-9